HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

María Reyes-Batlle Selected Research

Acanthamoeba Keratitis

6/2022Isobenzofuran-1(3H)-one derivatives: Amoebicidal activity and program cell death in Acanthamoeba castellanii Neff.
8/2021High oxygen concentrations inhibit Acanthamoeba spp.
5/2021Silver Nanoparticles Conjugated with Contact Lens Solutions May Reduce the Risk of Acanthamoeba Keratitis.
5/2020Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.
8/2019Ursolic Acid Derivatives as Potential Agents Against Acanthamoeba Spp.
6/2018Presence of Acanthamoeba in the ocular surface in a Spanish population of contact lens wearers.
1/2018Toxic effects of selected proprietary dry eye drops on Acanthamoeba.
1/2017Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts.
8/2015Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


María Reyes-Batlle Research Topics

Disease

9Acanthamoeba Keratitis
06/2022 - 08/2015
9Cysts
02/2022 - 01/2014
8Infections
06/2022 - 08/2015
6Amebiasis (Amoebiasis)
08/2019 - 02/2014
3Leishmaniasis
07/2016 - 06/2014
1Meningoencephalitis
06/2022
1Wounds and Injuries (Trauma)
12/2020
1Inflammation (Inflammations)
10/2020
1Blindness (Hysterical Blindness)
06/2018
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Glaucoma
12/2017
1Bacterial Infections (Bacterial Infection)
12/2017
1Neoplasms (Cancer)
12/2017
1Encephalitis (Encephalitis, Rasmussen)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
11/2014
1Erysipelas
11/2014
1Fever (Fevers)
10/2014
1Neglected Diseases
06/2014

Drug/Important Bio-Agent (IBA)

3ChlorhexidineIBA
01/2022 - 02/2014
3Adenosine Triphosphate (ATP)IBA
01/2021 - 12/2017
2Pharmaceutical PreparationsIBA
08/2021 - 06/2014
2SilverIBA
05/2021 - 05/2020
2Ophthalmic Solutions (Eye Drops)IBA
01/2021 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2020
2Voriconazole (Vfend)FDA LinkGeneric
02/2019 - 02/2014
2Anti-Bacterial Agents (Antibiotics)IBA
11/2014 - 11/2014
2AcidsIBA
11/2014 - 10/2014
1pitavastatin (itavastatin)FDA Link
02/2022
1cerivastatin (Kazak)FDA Link
02/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2022
1Rosuvastatin Calcium (Crestor)FDA Link
02/2022
1polihexanideIBA
01/2022
1Contact Lens Solutions (Contact Lens Solution)IBA
05/2021
1SoilIBA
01/2021
1Dexamethasone Drug Combination TobramycinFDA LinkGeneric
01/2021
1SolutionsIBA
12/2020
1Atorvastatin (Lipitor)FDA Link
10/2020
1FluvastatinFDA Link
10/2020
1Ursolic AcidIBA
08/2019
1Itraconazole (Sporanox)FDA LinkGeneric
02/2019
1Biological ProductsIBA
12/2017
1Timolol (Blocadren)FDA LinkGeneric
12/2017
1AntioxidantsIBA
12/2017
1ChromatinIBA
12/2017
1bisabolol (levomenol)IBA
06/2017
1Caffeine (No Doz)FDA LinkGeneric
01/2017
1maslinic acidIBA
01/2017
1Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
01/2017
1hexaazatrinaphthyleneIBA
07/2016
1oleuropeinIBA
11/2014
1AntibodiesIBA
11/2014
1VaccinesIBA
11/2014
1Doxycycline (Periostat)FDA LinkGeneric
10/2014
1Ciprofloxacin (Cipro)FDA LinkGeneric
10/2014
1olive leaf extractIBA
06/2014
1Myosins (Myosin)IBA
01/2014

Therapy/Procedure

7Contact Lenses
06/2022 - 08/2015
5Therapeutics
12/2020 - 11/2014
2Drug Therapy (Chemotherapy)
06/2022 - 08/2019
1Corneal Transplantation (Keratoplasty)
06/2018
1Highly Active Antiretroviral Therapy (HAART)
11/2014